Status | Study |
Completed |
Study Name: Open Label Clinical Trial of Anascorp® in Pediatric Patients With Scorpion Sting Envenomation Condition: Scorpion Sting Date: 2012-05-14 Interventions: Biological: Anascorp 3 vials of Alacramyn reconstituted in 50 ml of normal saline as an IV infusion over |
Completed |
Study Name: Open Label Study of Alacramyn® in Pediatric Patients With Scorpion Sting Envenomation Condition: Scorpion Sting Envenomation Date: 2012-05-14 Interventions: Biological: Antivenin Centruroides (scorpion) equine immune F(ab')2 3 vials of Alacramyn reconstituted i |
Completed |
Study Name: Compare Two Anti-Scorpion Venom Serum In Children Condition: Scorpion Sting Date: 2011-08-08 Interventions: Biological: Anti-scorpion venom serum Birmex |
Not yet recruiting |
Study Name: A Trial of Equine F (ab')2 Antivenom for Treatment of Scorpion Envenomation in Morocco Condition: Poisoning by Scorpion Sting Date: 2011-04-14 Interventions: Biological: Equine F(ab')2 antivenom |
Completed |
Study Name: Randomized Controlled Trial to Compare Two Anti-scorpion Serums Condition: Scorpion Sting Date: 2008-08-19 Interventions: Biological: serum antiscorpion The dose may be required for the patient according to clinical manifestat |
Completed |
Study Name: Establishment of Natural History of Scorpion Envenomation Condition: Scorpion Sting Envenomation Date: 2008-06-11 Interventions: Other: None, this is an observational study |
Completed |
Study Name: Double-Blind, Alacramyn® vs. Placebo in Pediatric Patients Condition: Scorpion Sting Envenomation Date: 2008-05-23 Interventions: Biological: Antivenin Centruroides (scorpion) equine immune F(ab)2 |
Completed |
Study Name: Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation Condition: Scorpion Sting Envenomation Date: 2007-12-26 Interventions: Drug: Antivenin Centruroides (scorpion) F(ab)2 Anascorp™ three vials diluted in 20 to 50 mL normal |